Recuvyra

RSS

Expired

This medicine's authorisation has expired

fentanyl
MedicineVeterinaryExpired

Italian is available via eTranslation, the European Commission's machine translation service.

Translate to Italian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Recuvyra has expired following the marketing-authorisation holder’s decision not to apply for a renewal.

български (BG) (568.84 KB - PDF)

Visualizza

español (ES) (537.02 KB - PDF)

Visualizza

čeština (CS) (573.8 KB - PDF)

Visualizza

dansk (DA) (511.6 KB - PDF)

Visualizza

Deutsch (DE) (515.35 KB - PDF)

Visualizza

eesti (ET) (539.37 KB - PDF)

Visualizza

ελληνικά (EL) (586.2 KB - PDF)

Visualizza

français (FR) (538.28 KB - PDF)

Visualizza

italiano (IT) (535.2 KB - PDF)

Visualizza

latviešu (LV) (569.81 KB - PDF)

Visualizza

lietuvių (LT) (534.12 KB - PDF)

Visualizza

magyar (HU) (548.34 KB - PDF)

Visualizza

Malti (MT) (576.33 KB - PDF)

Visualizza

Nederlands (NL) (513.44 KB - PDF)

Visualizza

polski (PL) (552.75 KB - PDF)

Visualizza

português (PT) (535.52 KB - PDF)

Visualizza

română (RO) (533.59 KB - PDF)

Visualizza

slovenčina (SK) (570.05 KB - PDF)

Visualizza

slovenščina (SL) (564.24 KB - PDF)

Visualizza

suomi (FI) (533.75 KB - PDF)

Visualizza

svenska (SV) (535.74 KB - PDF)

Visualizza

Product information

български (BG) (1.46 MB - PDF)

Visualizza

español (ES) (876.92 KB - PDF)

Visualizza

čeština (CS) (1.18 MB - PDF)

Visualizza

dansk (DA) (873.6 KB - PDF)

Visualizza

Deutsch (DE) (889.37 KB - PDF)

Visualizza

eesti (ET) (830.81 KB - PDF)

Visualizza

ελληνικά (EL) (1.51 MB - PDF)

Visualizza

français (FR) (864.23 KB - PDF)

Visualizza

hrvatski (HR) (875.28 KB - PDF)

Visualizza

italiano (IT) (859.62 KB - PDF)

Visualizza

latviešu (LV) (1.25 MB - PDF)

Visualizza

lietuvių (LT) (810.52 KB - PDF)

Visualizza

magyar (HU) (1.25 MB - PDF)

Visualizza

Malti (MT) (1.26 MB - PDF)

Visualizza

Nederlands (NL) (855.45 KB - PDF)

Visualizza

polski (PL) (1.23 MB - PDF)

Visualizza

português (PT) (838.3 KB - PDF)

Visualizza

română (RO) (1 MB - PDF)

Visualizza

slovenčina (SK) (1.18 MB - PDF)

Visualizza

slovenščina (SL) (1.13 MB - PDF)

Visualizza

suomi (FI) (858.03 KB - PDF)

Visualizza

svenska (SV) (851.7 KB - PDF)

Visualizza

Íslenska (IS) (879.42 KB - PDF)

Visualizza

norsk (NO) (836.37 KB - PDF)

Visualizza
Latest procedure affecting product information:IB/0009/G
13/10/2016

български (BG) (498.29 KB - PDF)

Visualizza

español (ES) (458.29 KB - PDF)

Visualizza

čeština (CS) (487.32 KB - PDF)

Visualizza

dansk (DA) (460.34 KB - PDF)

Visualizza

Deutsch (DE) (460.75 KB - PDF)

Visualizza

eesti (ET) (460.29 KB - PDF)

Visualizza

ελληνικά (EL) (495.78 KB - PDF)

Visualizza

français (FR) (460.31 KB - PDF)

Visualizza

hrvatski (HR) (471.53 KB - PDF)

Visualizza

italiano (IT) (460.57 KB - PDF)

Visualizza

latviešu (LV) (491.15 KB - PDF)

Visualizza

lietuvių (LT) (475.45 KB - PDF)

Visualizza

magyar (HU) (485.61 KB - PDF)

Visualizza

Malti (MT) (488.27 KB - PDF)

Visualizza

Nederlands (NL) (458.26 KB - PDF)

Visualizza

polski (PL) (485.72 KB - PDF)

Visualizza

português (PT) (460.24 KB - PDF)

Visualizza

română (RO) (474.03 KB - PDF)

Visualizza

slovenčina (SK) (487.71 KB - PDF)

Visualizza

slovenščina (SL) (477.71 KB - PDF)

Visualizza

suomi (FI) (458.28 KB - PDF)

Visualizza

svenska (SV) (460.23 KB - PDF)

Visualizza

Íslenska (IS) (457.47 KB - PDF)

Visualizza

norsk (NO) (461.18 KB - PDF)

Visualizza

Product details

Name of medicine
Recuvyra
Active substance
fentanyl
International non-proprietary name (INN) or common name
fentanyl
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QN02AB03

Pharmacotherapeutic group

Nervous system

Therapeutic indication

For the control of pain associated with orthopaedic and soft tissue surgery in dogs.

Authorisation details

EMA product number
EMEA/V/C/002239
Marketing authorisation holder
Eli Lilly and Company Limited 

Eli Lilly and Company Limited
Lilly House
Priestley Road
Basingstoke
Hampshire RG24 9NL
United Kingdom

Marketing authorisation issued
06/10/2011
Expiry of marketing authorisation
13/10/2016
Revision
4

Assessment history

This page was last updated on

Share this page